Key result
Biologic augmentation strategies in rotator cuff repair show mixed results for structural healing and functional scores due to a lack of standardized protocols.
Why the study?
High failure rates of rotator cuff repairs remain a concern, prompting the need to evaluate biologic augmentation strategies to improve healing and reduce retear rates.
Do biologic augmentation strategies improve healing and reduce retear rates in patients undergoing rotator cuff repair?
Do biologic augmentation strategies improve healing and reduce retear rates in patients undergoing rotator cuff repair?
Biologic augmentation holds promise for optimizing rotator cuff repairs, but widespread adoption requires large-scale human trials to establish standardized protocols.
No takes yet. Share an insight, caveat, or question.
Should not yet change rotator cuff repair practice; leaves open optimal protocols and efficacy pending standardized trials.
Saber et al. (2026) conducted a review in Rotator cuff repairs. Biologic augmentation strategies (e.g., platelet-rich plasma, mesenchymal stem cells, biologic scaffolds) was evaluated. Biologic augmentation strategies in rotator cuff repair show mixed results for structural healing and functional scores due to a lack of standardized protocols.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: